Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Mar 28, 2025, 4:00 PM
1.350
+0.030 (2.25%)
After-hours: Mar 28, 2025, 5:59 PM EDT
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $63.70 million as of March 28, 2025. Its market cap has decreased by -6.38% in one year.
Market Cap
63.70M
Enterprise Value
-53.16M
1-Year Change
-6.38%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $63.70M, a decrease of -88.49%. That is a compound annual growth rate of -41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 63.70M | -19.51% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |